Physical Activity in Older Patients With Acute Myeloid Leukemia Undergoing Chemotherapy

• Percentage of adults 50 years of age or older admitted for induction or reinduction chemotherapy for acute myeloid leukemia (AML) who are eligible for the study [ Time Frame: day 1 ] [ Designated as safety issue: No ]
  
• Percentage of eligible patients recruited into the study [ Time Frame: day 1 ] [ Designated as safety issue: No ]
  
• Number and frequency of reported barriers to eligibility and enrollment [ Time Frame: day 1 ] [ Designated as safety issue: No ]
  
• Percentage of study participants who successfully completed the physical and the psychosocial measures [ Time Frame: week 13 ] [ Designated as safety issue: No ]
  
• Record barriers to completion of the physical activity program [ Time Frame: week 13 ] [ Designated as safety issue: No ]
  

• Physical function as measured by the Short Physical Performance Battery (SPPB) [ Time Frame: week 13 ] [ Designated as safety issue: No ]
  
• Quality of Life as measured with the Distress Thermometer [ Time Frame: week 13 ] [ Designated as safety issue: No ]
  

Behavioral: exercise intervention
participation in physical activity intervention program weeks 2 through 5

OBJECTIVES:

Primary

• To test the feasibility of conducting a physical activity intervention in hospitalized older adults with acute myeloid leukemia (AML) undergoing induction or reinduction chemotherapy.

Secondary

• To obtain preliminary data regarding the effectiveness of a physical activity intervention on physical function, quality of life, and treatment-related symptoms in these patients.

OUTLINE: Patients undergo a baseline evaluation in week 1 focusing on basic demographics, health, physical function and quality-of-life assessments. These assessments include the Short Physical Performance Battery (SPPB); the Hand Grip Test of Muscular Strength; the Demographics and Physical Activity History; the Functional Assessment of Cancer Therapy (FACT-Leu); the Distress Thermometer; the Short-form Positive Affect Schedule (PANAS-SF); the Satisfaction with Life Scale (SWL); the FAST-23 Disability Measure; the Center for Epidemiologic Studies Depression Scale Short Form (CES-D); the Self-efficacy for Physical Activity Scale; the Intervention Feedback Form; and the Pre-Post Session Ratings. Some medical data may be obtained from the patient's medical record to assist in these assessments.

Beginning in weeks 2-5, patients undergo a 30-minute orientation to the exercise sessions that will be tailored to individual needs and abilities. Patients undergo a 30- to 45-minute group physical activity session twice a week, and a supervised individual session following the same format as the group session, once a week for 4 weeks. After completion of the physical activity intervention, patients complete an activities packet and repeat the physical function and quality of life assessments in weeks 5-6 and again upon readmission for consolidation therapy in weeks 9-13 .

After completion of study intervention, patients are followed for 4 months.